Prednisone Withdrawn Phase 2 Trials for Castrate-resistant Metastatic Prostate Cancer Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01750866Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer